DATED THIS DAY OF 05 OCT 2020 BETWEEN GENEREX BIOTECHNOLOGY CORPORATION ("GENEREX") AND NUGENEREX IMMUNO-ONCOLOGY, INC. (''NUGENEREX") AND BINTAI HEALTHCARE SDN BHD ("BHSB") DISTRIBUTION AND LICENSING AGREEMENTDistribution and Licensing Agreement • October 14th, 2020 • Nugenerex Immuno-Oncology, Inc. • Pharmaceutical preparations
Contract Type FiledOctober 14th, 2020 Company IndustryNuGenerex Immuno-Oncology, Inc. a majority owned subsidiary of Generex Biotechnology Corporation, each a Delaware corporation with an office address of 10102 USA Today Way, Miramar, FL 33025 ("NuGenerex")